Literature DB >> 22613066

A theoretical and spectroscopic study of co-amorphous naproxen and indomethacin.

Korbinian Löbmann1, Riikka Laitinen, Holger Grohganz, Clare Strachan, Thomas Rades, Keith C Gordon.   

Abstract

Co-amorphous drug systems were recently introduced as potential drug delivery systems for poorly water soluble drugs in order to overcome problems associated with amorphous materials. The improved physical stability and dissolution of these systems was attributed to molecular interactions between the co-amorphous partners, such as hydrogen bonds. However, molecular level characterization with vibrational spectroscopy of even the amorphous drugs alone presents a significant challenge. This becomes even more complicated when more than one compound is present in the material under investigation. In this study, the co-amorphous drug mixture containing naproxen (NAP) and indomethacin (IND) was investigated using infrared spectroscopy (IR) and quantum mechanical calculations. The structures of both drugs were optimized as monomer, homodimer and heterodimer using density functional theory and used for the calculation of IR spectra. Conformational analysis confirmed that the optimized structures were suitable for the theoretical prediction of the spectra. Vibrational modes from the calculation could be matched with experimentally observed spectra for crystalline and amorphous NAP and IND, and it could be shown that both drugs exist as homodimers in their respective individual amorphous form. With the results from the experimental single amorphous drugs and theoretical homodimers, a detailed analysis of the experimental co-amorphous and theoretical heterodimer spectra was performed and evaluated. It is suggested that NAP and IND exist as heterodimers in the co-amorphous mixture when quench cooled together from the melt in a 1:1 molar ratio.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Co-amorphous; Density functional theory; Infrared spectroscopy; Naproxen-indomethacin; Quantum mechanical chemistry

Mesh:

Substances:

Year:  2012        PMID: 22613066     DOI: 10.1016/j.ijpharm.2012.05.016

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  A Strategy for Co-former Selection to Design Stable Co-amorphous Formations Based on Physicochemical Properties of Non-steroidal Inflammatory Drugs.

Authors:  Hiroshi Ueda; Noriyuki Muranushi; Satoshi Sakuma; Yasuo Ida; Takeshi Endoh; Kazunori Kadota; Yuichi Tozuka
Journal:  Pharm Res       Date:  2015-12-24       Impact factor: 4.200

2.  A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide.

Authors:  Meiling Su; Yanming Xia; Yajing Shen; Weili Heng; Yuanfeng Wei; Linghe Zhang; Yuan Gao; Jianjun Zhang; Shuai Qian
Journal:  RSC Adv       Date:  2020-01-02       Impact factor: 4.036

3.  Improving co-amorphous drug formulations by the addition of the highly water soluble amino Acid, proline.

Authors:  Katrine Tarp Jensen; Korbinian Löbmann; Thomas Rades; Holger Grohganz
Journal:  Pharmaceutics       Date:  2014-07-14       Impact factor: 6.321

Review 4.  Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery.

Authors:  Anna Karagianni; Kyriakos Kachrimanis; Ioannis Nikolakakis
Journal:  Pharmaceutics       Date:  2018-07-19       Impact factor: 6.321

5.  Fluoroquinolone Amorphous Polymeric Salts and Dispersions for Veterinary Uses.

Authors:  Hanah Mesallati; Anita Umerska; Lidia Tajber
Journal:  Pharmaceutics       Date:  2019-06-09       Impact factor: 6.321

6.  Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy.

Authors:  Marcin Skotnicki; Barbara Jadach; Agnieszka Skotnicka; Bartłomiej Milanowski; Lidia Tajber; Marek Pyda; Jacek Kujawski
Journal:  Pharmaceutics       Date:  2021-01-18       Impact factor: 6.321

7.  A Multivariate Approach for the Determination of the Optimal Mixing Ratio of the Non-Strong Interacting Co-Amorphous System Carvedilol-Tryptophan.

Authors:  Rong Di; Jingwen Liu; Holger Grohganz; Thomas Rades
Journal:  Molecules       Date:  2021-02-04       Impact factor: 4.411

8.  Influence of Solvent Composition on the Performance of Spray-Dried Co-Amorphous Formulations.

Authors:  Jaya Mishra; Thomas Rades; Korbinian Löbmann; Holger Grohganz
Journal:  Pharmaceutics       Date:  2018-04-12       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.